| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Barbara White | |
| Sergei P. Atamas | |||
| P2860 | cites work | Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial. | Q53560049 |
| Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. | Q53904392 | ||
| Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies. | Q53923977 | ||
| Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. | Q54346034 | ||
| Increased Plasma Levels of Platelet-Derived Growth Factor Activity in Patients with Progressive Systemic Sclerosis | Q59697292 | ||
| Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts | Q22254093 | ||
| Interleukin-4 regulates connective tissue growth factor expression in human lung fibroblasts | Q24294858 | ||
| Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific | Q24798801 | ||
| A new direction in the pathogenesis of idiopathic pulmonary fibrosis? | Q24798888 | ||
| The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis | Q28137622 | ||
| Induction of heat shock protein 47 synthesis by TGF-beta and IL-1 beta via enhancement of the heat shock element binding activity of heat shock transcription factor 1 | Q28216803 | ||
| Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice | Q28345267 | ||
| TGF-beta is a critical mediator of acute lung injury | Q28367079 | ||
| Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung | Q28367151 | ||
| Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors | Q28573949 | ||
| Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
| Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition | Q30306117 | ||
| Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. | Q30903476 | ||
| Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes. | Q31902298 | ||
| TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). | Q31903554 | ||
| Spontaneous Activation of Transforming Growth Factor-β Gene Transcription in Broncho-Alveolar Mononuclear Cells of Individuals with Systemic Autoimmune Diseases with Lung Involvement | Q33331533 | ||
| Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A. | Q33851819 | ||
| Alternative versus classical activation of macrophages. | Q33868142 | ||
| Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma | Q42519388 | ||
| Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. | Q42528018 | ||
| Fibroblast selection in scleroderma. An alternative model of fibrosis | Q42670041 | ||
| Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. | Q42824637 | ||
| Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound | Q42832589 | ||
| Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. | Q43577998 | ||
| Thrombin promotes fibroblast proliferation during the early stages of experimental radiation pneumonitis | Q43647761 | ||
| Impairment of bleomycin-induced lung fibrosis in CD28-deficient mice | Q43699047 | ||
| Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis | Q43735893 | ||
| Protection from pulmonary fibrosis in the absence of CCR2 signaling | Q43760123 | ||
| Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases | Q43878448 | ||
| Elevated expression of the genes encoding TNF-alpha and thromboxane synthase in leucocytes from patients with systemic sclerosis | Q44087201 | ||
| Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters | Q44128862 | ||
| Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts | Q44159763 | ||
| Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. | Q44185732 | ||
| Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma | Q44213853 | ||
| Response of scleroderma fibroblasts to various growth factors | Q44260904 | ||
| Recombinant interferon-gamma in the treatment of systemic sclerosis | Q44609493 | ||
| Effect of histamine on collagen and collagen m-RNA production in human skin fibroblasts | Q45262375 | ||
| Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. | Q45945382 | ||
| Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. | Q46156191 | ||
| African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease | Q46905919 | ||
| Collagen synthesis in scleroderma: selection of fibroblast populations during subcultures. | Q49220469 | ||
| Severe restrictive lung disease in systemic sclerosis. | Q50600064 | ||
| Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung. | Q50782228 | ||
| Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. | Q51716667 | ||
| Role of p38 MAPK in Transforming Growth Factor β Stimulation of Collagen Production by Scleroderma and Healthy Dermal Fibroblasts | Q60537806 | ||
| Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma Phenotype | Q60537838 | ||
| Oncostatin M Stimulates Transcription of the Human α2(I) Collagen Gene via the Sp1/Sp3-binding Site | Q60537839 | ||
| Increased Expression of CD40 Ligand in Activated CD4+T Lymphocytes of Systemic Sclerosis Patients | Q61628558 | ||
| Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization | Q61733728 | ||
| Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host disease | Q62929586 | ||
| Cytokine production and serum levels in systemic sclerosis | Q67593361 | ||
| Increased sensitivity of scleroderma fibroblasts in culture to stimulation of protein and collagen synthesis by serum | Q67672931 | ||
| Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma | Q67999243 | ||
| Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation | Q68097944 | ||
| Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts | Q68167537 | ||
| Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts | Q68190973 | ||
| Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? | Q68700570 | ||
| Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization | Q68717457 | ||
| Evaluation and management of scleroderma lung disease using bronchoalveolar lavage | Q68779304 | ||
| Interleukin-1 inhibits the synthesis of collagen by fibroblasts | Q68812123 | ||
| Prevalence of scleroderma spectrum disorders in the general population of South Carolina | Q69742881 | ||
| Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells | Q70224807 | ||
| Transforming growth factor (TGF beta) decreases the proliferation of human bone marrow fibroblasts by inhibiting the platelet-derived growth factor (PDGF) binding | Q70226496 | ||
| Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta | Q70534310 | ||
| Investigation of type I and type III collagens of the lung in progressive systemic sclerosis | Q70719615 | ||
| Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis | Q70768301 | ||
| Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases | Q71089537 | ||
| The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury | Q71189434 | ||
| Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor | Q71381389 | ||
| c-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation | Q71383665 | ||
| Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis | Q71574576 | ||
| Restricted T-cell antigen receptor repertoire in bronchoalveolar T cells from normal humans | Q71688731 | ||
| Chemotactic cytokines mediate leukocyte recruitment in fibrotic lung disease | Q71725323 | ||
| Elevated levels of eosinophil major basic protein in the sera of patients with systemic sclerosis | Q71880216 | ||
| Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma | Q71965468 | ||
| Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosis | Q71994942 | ||
| Interleukin-4 acts as a potent stimulator for expression of monocyte chemoattractant JE/MCP-1 in mouse peritoneal macrophages | Q72159597 | ||
| Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts | Q72353150 | ||
| Hapten-immune pulmonary interstitial fibrosis (HIPIF) in mice requires both CD4+ and CD8+ T lymphocytes | Q72656480 | ||
| Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro | Q72694022 | ||
| Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets | Q72769840 | ||
| Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP | Q73042158 | ||
| Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases | Q73068961 | ||
| Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis | Q73076887 | ||
| Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGF | Q73081964 | ||
| Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis | Q73092717 | ||
| Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma | Q73160811 | ||
| Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma | Q73199131 | ||
| Increased interleukin-17 production in patients with systemic sclerosis | Q73202422 | ||
| Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis | Q73205591 | ||
| Interferon-gamma and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblasts | Q73208038 | ||
| Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts | Q34020430 | ||
| Deficient Smad7 expression: a putative molecular defect in scleroderma | Q34021184 | ||
| Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype | Q34388421 | ||
| Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing. | Q34390977 | ||
| Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair | Q34437758 | ||
| Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast | Q34467951 | ||
| Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis | Q34747455 | ||
| Complex cytokine regulation of tissue fibrosis | Q35017833 | ||
| Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease | Q35022204 | ||
| Smooth muscle differentiation in scleroderma fibroblastic cells | Q35811553 | ||
| Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts | Q36231258 | ||
| Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation | Q36231523 | ||
| Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice | Q36287478 | ||
| Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation | Q36350622 | ||
| Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide | Q36354096 | ||
| Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta) | Q36429520 | ||
| TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event | Q36844219 | ||
| Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway | Q38296390 | ||
| Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma | Q38327005 | ||
| C-myb, but not B-myb, upregulates type I collagen gene expression in human fibroblasts | Q38328184 | ||
| Characterization of the c-Myb-responsive region and regulation of the human type I collagen alpha 2 chain gene by c-Myb. | Q38361182 | ||
| Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. | Q40348725 | ||
| Interstitial lung disease of systemic sclerosis. | Q40468554 | ||
| Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis | Q40625104 | ||
| Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis | Q40740841 | ||
| Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling | Q40756159 | ||
| The differentiation and function of myofibroblasts is regulated by mast cell mediators | Q40768319 | ||
| Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis | Q40802755 | ||
| Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts | Q40852538 | ||
| Thrombin stimulates the expression of PDGF in lung epithelial cells | Q40859180 | ||
| Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma | Q41005869 | ||
| Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4 | Q41020866 | ||
| Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung | Q41068693 | ||
| Effect of histamine on proliferation of normal human adult lung fibroblasts | Q41131152 | ||
| T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice | Q41207867 | ||
| Elevated plasma histamine levels in systemic sclerosis (scleroderma). | Q41224949 | ||
| Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor | Q41479307 | ||
| Alternative splice variants of cytokines: making a list | Q41604776 | ||
| Significant Correlation Between Connective Tissue Growth Factor Gene Expression and Skin Sclerosis in Tissue Sections from Patients with Systemic Sclerosis | Q41679291 | ||
| Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts | Q41700398 | ||
| Secretion and binding of transforming growth factor beta by scleroderma and normal dermal fibroblasts. | Q41735665 | ||
| The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts | Q41766529 | ||
| Interleukin-1 beta prevents the stimulatory effect of transforming growth factor-beta on collagen gene expression in human skin fibroblasts | Q41771855 | ||
| Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts | Q41955517 | ||
| Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts | Q41963379 | ||
| Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts | Q42120199 | ||
| Enhanced production of interleukin-1 and tumor necrosis factor alpha by cultured peripheral blood monocytes from patients with scleroderma | Q42122302 | ||
| Eosinophils adhere to and stimulate replication of lung fibroblasts 'in vitro'. | Q42473152 | ||
| Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene | Q42494727 | ||
| CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling | Q42498294 | ||
| Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation | Q42505740 | ||
| IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling | Q42518399 | ||
| Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis | Q73211913 | ||
| Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis | Q73218951 | ||
| Interferon-gamma inhibits experimental renal fibrosis | Q73265447 | ||
| Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo | Q73368701 | ||
| Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis | Q73385986 | ||
| Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-gamma activation | Q73407827 | ||
| Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts | Q73478890 | ||
| Antagonistic effects of interferon-gamma and interleukin-4 on fibroblast cultures | Q73555252 | ||
| Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors | Q73565858 | ||
| Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages | Q73567478 | ||
| Pulmonary capillary endothelial dysfunction in early systemic sclerosis | Q73792172 | ||
| Endothelin-1 secretion by alveolar macrophages in systemic sclerosis | Q73885856 | ||
| Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis | Q73905511 | ||
| Depletion of protein kinase Cepsilon in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression | Q74024142 | ||
| Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression | Q74024150 | ||
| Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway | Q74108320 | ||
| Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts | Q74242439 | ||
| Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis | Q74267115 | ||
| Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis | Q74452502 | ||
| Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis | Q74568092 | ||
| High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts | Q74602329 | ||
| Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis | Q77179324 | ||
| Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma | Q77460965 | ||
| Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families | Q77625551 | ||
| Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation | Q77743777 | ||
| Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis | Q77872996 | ||
| Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat | Q77900005 | ||
| Expression of C-C chemokines in bronchoalveolar lavage cells from patients with granulomatous lung diseases | Q77928975 | ||
| Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary | Q77995169 | ||
| Gene expression in bronchoalveolar lavage cells from scleroderma patients | Q77995648 | ||
| Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma | Q78021748 | ||
| Antagonistic effects of an alternative splice variant of human IL-4, IL-4delta2, on IL-4 activities in human monocytes and B cells | Q78109962 | ||
| Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis | Q78169196 | ||
| Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation | Q78505493 | ||
| Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis | Q78576655 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| pulmonary fibrosis | Q32446 | ||
| P304 | page(s) | 537-550 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Cytokine and Growth Factor Reviews | Q15763303 |
| P1476 | title | Cytokine regulation of pulmonary fibrosis in scleroderma | |
| P478 | volume | 14 |
| Q35878705 | A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-ph |
| Q24814682 | Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach |
| Q37728816 | Bleomycin induces upregulation of lysyl oxidase in cultured human fetal lung fibroblasts |
| Q37350899 | Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients |
| Q84474506 | CD8+ T cells in systemic sclerosis |
| Q34154288 | Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease |
| Q34007288 | Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease |
| Q36093857 | Caveolin-1 signaling in lung fibrosis |
| Q35916001 | Complex regulation of pulmonary inflammation and fibrosis by CCL18 |
| Q90656583 | Critical role of inflammatory mast cell in fibrosis: Potential therapeutic effect of IL-37 |
| Q42113962 | Cytokines in chronic respiratory diseases |
| Q42580022 | Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis |
| Q41882445 | Diagnostic and therapeutic strategies for eosinophilic esophagitis |
| Q44547443 | Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis |
| Q34051566 | Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis. |
| Q37596505 | Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury |
| Q42466834 | Exercise in systemic sclerosis intensifies systemic inflammation and oxidative stress |
| Q34995163 | Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts. |
| Q25255751 | Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma |
| Q54367655 | GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production. |
| Q28083733 | Gene expression profiling offers insights into the role of innate immune signaling in SSc |
| Q34257607 | Histone deacetylase: a potential therapeutic target for fibrotic disorders |
| Q34685461 | Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology |
| Q47440709 | Increased expression of Interleukin-13 and connective tissue growth factor, and their potential roles during foreign body encapsulation of subcutaneous implants |
| Q51582879 | Influence of the anti-inflammatory cytokine interleukin-4 on human joint capsule myofibroblasts. |
| Q47860407 | Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung |
| Q37596499 | Interleukin-33 potentiates bleomycin-induced lung injury |
| Q33944898 | Interleukins 4 and 13 modulate gene expression and promote proliferation of primary human tenocytes |
| Q80839683 | Interstitial lung disease in systemic sclerosis |
| Q34310766 | Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts |
| Q33760755 | Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts |
| Q37686310 | Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon |
| Q53649613 | Mast cells, which interact with Escherichia coli, up-regulate genes associated with innate immunity and become less responsive to Fc(epsilon)RI-mediated activation. |
| Q36237168 | Molecular and cellular mechanisms of pulmonary fibrosis |
| Q38772739 | Myeloid Populations in Systemic Autoimmune Diseases. |
| Q37921386 | Myofibroblast differentiation and survival in fibrotic disease |
| Q41921280 | Naringenin Ameliorates Acute Inflammation by Regulating Intracellular Cytokine Degradation. |
| Q38255314 | Paclitaxel-induced diffuse cutaneous sclerosis: a case with associated esophageal dysmotility, Raynaud's phenomenon, and myositis |
| Q40270644 | Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles. |
| Q36903365 | Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus |
| Q26779081 | Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases |
| Q37365318 | Recent advances in the treatment of systemic sclerosis |
| Q36232198 | Regulation of inflammation by interleukin-4: a review of "alternatives" |
| Q39247110 | Relief from within: a peptide therapy for fibrosis |
| Q35121494 | Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? |
| Q40001918 | Serum concentrations of cyclooxygenase-2 in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis |
| Q33829507 | Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays |
| Q37637273 | Stellate Cell Activation and Imbalanced Expression of TGF-β1/TGF-β3 in Acute Autoimmune Liver Lesions Induced by ConA in Mice. |
| Q42472501 | Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma). |
| Q34888501 | Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms. |
| Q38177343 | TGF-β1 as a therapeutic target for pulmonary fibrosis and COPD. |
| Q83149985 | The efficiency of a urotensin II antagonist in an experimental lung fibrosis model |
| Q35591011 | The role of macrophage migration inhibitory factor in mast cell-stimulated fibroblast proliferation and collagen production |
| Q89460324 | Transcriptome changes in muscle of Nellore cows submitted to recovery weight gain under grazing condition |
| Q42181812 | Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis |
Search more.